Supplementary Table 1High-risk factors for the survival of HBV-related HCC on entire enrolled patients
| Univariable |
Multivariable |
|||
|---|---|---|---|---|
| HR (95%CI) | P | HR (95%CI) | P | |
| Age ≥60 years | 1.292 (1.100–1.518) | 0.002 | 1.209 (1.027–1.424) | 0.023 |
| Male | 1.470 (1.171–1.845) | 0.001 | 1.293 (1.025–1.631) | 0.030 |
| ALB <35 g/L | 2.826 (2.424–3.295) | <0.001 | 1.491 (1.248–1.780) | <0.001 |
| AST ≥80 U/L | 3.863 (3.292–4.532) | <0.001 | 1.818 (1.517–2.177) | <0.001 |
| TBIL ≥34 μmol/L | 2.975 (2.514–3.521) | <0.001 | 1.174 (0.964–1.430) | 0.111 |
| PLT <100 × 109/L | 1.669 (1.434–1.942) | <0.001 | 1.114 (0.946–1.313) | 0.196 |
| AFP (take <20 ng/mL as a reference) | ||||
| 20–400 ng/mL | 3.505 (2.825–4.349) | <0.001 | 2.284 (1.830–2.852) | <0.001 |
| ≥400 ng/mL | 5.724 (4.583–7.149) | <0.001 | 2.746 (2.168–3.479) | <0.001 |
| LSM (take <9 kPa as a reference) | ||||
| 9–22 kPa | 2.846 (2.120–3.822) | <0.001 | 2.266 (1.684–3.049) | <0.001 |
| ≥22 kPa | 8.333 (6.213–11.176) | <0.001 | 4.326 (3.201–5.847) | <0.001 |
| BCLC (take 0/A as a reference) | ||||
| B/C | 6.386 (5.292–7.706) | <0.001 | 4.079 (3.348–4.971) | <0.001 |
| D | 27.574 (20.173–37.690) | <0.001 | 16.830 (12.048–23.509) | <0.001 |
Note: ALB albumin; AST, aspartate aminotransferase; TBIL, total bilirubin; PLT, platelet; AFP, alpha-fetoprotein; LSM, liver stiffness measurement; BCLC, Barcelona Clinic Liver Cancer; HR, hazard ratio; CI, confidence interval.